微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 58.43% | 0.15% | 0.14% | 60/140 | 52.37% | 迈克生物 | 57.29% | 行业排名> |
| 2025-12-31 | 58.35% | 0.74% | -0.07% | 60/140 | 51.9% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-09-30 | 58.39% | 0.43% | -0.32% | 60/140 | 52.23% | 佰仁医疗 | 89.18% | 行业排名> |
| 2025-06-30 | 58.58% | -0.25% | 0.4% | 62/140 | 52.43% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-03-31 | 58.34% | -2.18% | 0.73% | 57/140 | 52.13% | 佰仁医疗 | 88.54% | 行业排名> |
| 2024-12-31 | 57.92% | 1.02% | -0.38% | 62/140 | 53.08% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-09-30 | 58.14% | 0.51% | -0.99% | 62/140 | 53.87% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-06-30 | 58.72% | 1.15% | -1.54% | 61/140 | 53.95% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-03-31 | 59.64% | 2.96% | 4.03% | 55/140 | 53.88% | 佰仁医疗 | 89.27% | 行业排名> |
| 2023-12-31 | 57.33% | 1.93% | -0.88% | 62/140 | 53.57% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-09-30 | 57.84% | 4.43% | -0.37% | 62/140 | 54.44% | 正海生物 | 89.9% | 行业排名> |
| 2023-06-30 | 58.06% | 5.72% | 0.22% | 60/140 | 53.81% | 正海生物 | 90.39% | 行业排名> |
| 2023-03-31 | 57.93% | 4.93% | 2.99% | 57/140 | 54.06% | 正海生物 | 90.3% | 行业排名> |
| 2022-12-31 | 56.25% | 0.51% | 1.55% | 66/140 | 54.01% | 万泰生物 | 91.61% | 行业排名> |
| 2022-09-30 | 55.39% | -0.99% | 0.86% | 68/140 | 55.7% | 三友医疗 | 90.18% | 行业排名> |
| 2022-06-30 | 54.92% | -2.15% | -0.53% | 72/140 | 55.37% | 三友医疗 | 90.14% | 行业排名> |
| 2022-03-31 | 55.21% | -2.33% | -1.35% | 67/140 | 56.89% | 三友医疗 | 90.29% | 行业排名> |
| 2021-12-31 | 55.97% | -5.8% | 0.04% | 76/140 | 57.98% | 三友医疗 | 90.73% | 行业排名> |
| 2021-09-30 | 55.94% | -6.31% | -0.32% | 68/140 | 59.77% | 三友医疗 | 90.5% | 行业排名> |
| 2021-06-30 | 56.12% | -6.8% | -0.71% | 72/140 | 59.05% | 三友医疗 | 90.29% | 行业排名> |
| 2021-03-31 | 56.52% | -2.78% | -4.86% | 63/140 | 61.5% | 正海生物 | 90.78% | 行业排名> |
| 2020-12-31 | 59.41% | 6.2% | -0.5% | 69/140 | 60.12% | 正海生物 | 91.59% | 行业排名> |
| 2020-09-30 | 59.71% | 6.85% | -0.85% | 51/140 | 62.21% | 正海生物 | 92.23% | 行业排名> |
| 2020-06-30 | 60.22% | 7.13% | 3.58% | 59/140 | 60.36% | 正海生物 | 92.69% | 行业排名> |
| 2020-03-31 | 58.14% | 2.4% | 3.93% | 43/140 | 58.8% | 正海生物 | 92.61% | 行业排名> |
| 2019-12-31 | 55.94% | 2.46% | 0.11% | 63/140 | 56.96% | 正海生物 | 94.38% | 行业排名> |
| 2019-09-30 | 55.88% | 2.16% | -0.59% | 32/140 | 55.83% | 正海生物 | 93.12% | 行业排名> |
| 2019-06-30 | 56.21% | 3.34% | -1% | 40/140 | 57.93% | 正海生物 | 93.78% | 行业排名> |
| 2019-03-31 | 56.78% | 3.59% | 3.99% | 24/140 | 52.61% | 正海生物 | 93.09% | 行业排名> |
| 2018-12-31 | 54.6% | -1.75% | -0.18% | 60/140 | 56.22% | 正海生物 | 93.85% | 行业排名> |
| 2018-09-30 | 54.7% | -2.33% | 0.56% | 25/140 | 52.76% | 正海生物 | 93.08% | 行业排名> |
| 2018-06-30 | 54.39% | -3.33% | -0.76% | 28/140 | 53.06% | 正海生物 | 92.83% | 行业排名> |
| 2018-03-31 | 54.81% | -2.11% | -1.37% | 24/140 | 52.55% | 正海生物 | 92.44% | 行业排名> |
| 2017-12-31 | 55.57% | 1.37% | -0.77% | 55/140 | 56.1% | 正海生物 | 92.7% | 行业排名> |
| 2017-09-30 | 56% | 2.33% | -0.46% | 21/140 | 53.53% | 正海生物 | 93.67% | 行业排名> |
| 2017-06-30 | 56.26% | 3.2% | 0.49% | 29/140 | 54.85% | 正海生物 | 94.14% | 行业排名> |
| 2017-03-31 | 55.99% | 4.06% | 2.13% | 19/140 | 54.29% | 正海生物 | 93.83% | 行业排名> |
| 2016-12-31 | 54.82% | 3.89% | 0.17% | 43/140 | 57.35% | 正海生物 | 93.69% | 行业排名> |
| 2016-09-30 | 54.73% | 4.59% | 0.39% | 17/140 | 51.85% | 正海生物 | 92.79% | 行业排名> |
| 2016-06-30 | 54.52% | 3.4% | 1.33% | 23/140 | 52.6% | 健帆生物 | 84.23% | 行业排名> |
| 2016-03-31 | 53.8% | 1.27% | 1.96% | 15/140 | 50.24% | *ST明德 | 86.71% | 行业排名> |